| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 08/13/2003 | EP1073658B1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 08/13/2003 | CN1436184A Substd. pyridine herbicides |
| 08/13/2003 | CN1436173A Hydroxy formamidine derivs. and medicines contg. same |
| 08/13/2003 | CN1436172A 1,2-dihydropyridine compounds, process for preparation of same and use thereof |
| 08/13/2003 | CN1117748C Herbicidal 2,6-disubstd. pyridines and 2,4-disubstd. pyrimidines |
| 08/13/2003 | CN1117733C Process for synthesis of ribonucleotide reductase inhibitors 3-AP and 3-AMP |
| 08/13/2003 | CN1117732C Noval Dihydronaphthalene compound and process for producing same |
| 08/12/2003 | US6605725 Treating a central or peripheral nervous system disorder or condition through modulation of a voltage-dependent potassium channel |
| 08/12/2003 | US6605639 Treating and/or preventing diseases alleviated by retinoid X receptor ligand dependent transcriptional regulation using ascochlorin or derivatives |
| 08/12/2003 | US6605632 Affinity for melatonin receptors |
| 08/12/2003 | US6605626 Antithrombotic agents |
| 08/12/2003 | US6605625 Antiarrhythmia agents |
| 08/12/2003 | US6605620 Cyclic amine compounds and pharmaceutical composition containing the same |
| 08/12/2003 | US6605612 Cardioprotective phosohonates and malonates |
| 08/12/2003 | US6605608 Amino acid derivatives and drugs containing the same as the active ingredient |
| 08/12/2003 | US6605323 Monostable ferroelectric active matrix display |
| 08/12/2003 | US6605201 Charge transfer compounds comprising osmium compounds coupled to polymers, used as biosensors |
| 08/12/2003 | US6605200 Polymeric transition metal complexes and uses thereof |
| 08/12/2003 | US6605124 Naphthol hair dyes for keratinous fibers |
| 08/07/2003 | WO2003064685A2 Genetic polymorphisms in the preprotachykinin gene |
| 08/07/2003 | WO2003064424A2 Water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases |
| 08/07/2003 | WO2003064391A1 Metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid |
| 08/07/2003 | WO2003064390A1 Process for preparing integrin antagonist intermediate |
| 08/07/2003 | WO2003064376A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps) |
| 08/07/2003 | WO2003064369A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 08/07/2003 | WO2003063797A2 Cycloalkyl inhibitors of potassium channel function |
| 08/07/2003 | WO2003063576A2 Arylsulfonamidobenzylic compounds |
| 08/07/2003 | US20030149250 Labeled compounds useful in imaging amyloid deposits and useful for inhibiting the aggregation of amyloid protein to form amyloid deposit |
| 08/07/2003 | US20030149108 Linked biaryl compounds |
| 08/07/2003 | US20030149107 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 08/07/2003 | US20030149087 For therapy of atherosclerosis, gallstone disease, lipid disorders, obesity or a cardiovascular disorder |
| 08/07/2003 | US20030149052 Side effect reduction |
| 08/07/2003 | US20030149039 For therapy of disease responsive to antagonist modulation of the Neurokinin-1 (NK-1) receptor in a patient |
| 08/07/2003 | US20030149023 Novel compounds with analgesic effect |
| 08/07/2003 | US20030149017 For therapy and prophylaxis of migraine, inflammatory diseases, stroke, acute and chronic pain, hypovolemic shock, traumatic shock, reperfusion injury, Crohn's disease, ulcerative colitis, septic shock, multiple sclerosis, etc. |
| 08/07/2003 | US20030149015 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives |
| 08/07/2003 | US20030147845 O2-arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1-[(2-carboxylato) pyrrolidin-1-yl]diazen-1-ium-1,2-diolates |
| 08/07/2003 | CA2474451A1 Cycloalkyl inhibitors of potassium channel function |
| 08/07/2003 | CA2474433A1 Arylsulfonamidobenzylic compounds |
| 08/07/2003 | CA2473984A1 Metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid |
| 08/07/2003 | CA2473162A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 08/07/2003 | CA2473128A1 Genetic polymorphisms in the preprotachykinin gene |
| 08/06/2003 | EP1333027A1 Production method of insecticidal and/or acaricidal ether compounds and intermediates thereof |
| 08/06/2003 | EP1332132A2 Enamine derivatives as cell adhesion molecules |
| 08/06/2003 | EP1332131A2 Acid derivatives useful as serine protease inhibitors |
| 08/06/2003 | EP1332127A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 08/06/2003 | EP1331918A1 Primary intermediates for oxidative coloration of hair |
| 08/06/2003 | EP1189929B1 Factor viia inhibitors |
| 08/06/2003 | EP1049537B1 Catalytic compositions and methods for asymmetric allylic alkylation |
| 08/06/2003 | CN1434800A Pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compunds |
| 08/06/2003 | CN1434046A Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof |
| 08/06/2003 | CN1434044A Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof |
| 08/06/2003 | CN1434043A Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof |
| 08/06/2003 | CN1434038A Production method for ether compound |
| 08/06/2003 | CN1434037A Nove intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof |
| 08/06/2003 | CN1434036A Pyridine structure contained fluorine-aromatic diamine and preparation process and use thereof |
| 08/06/2003 | CN1117080C Method for producing (hetero) aromatic hydroxylamines |
| 08/06/2003 | CN1117078C Improvedmethod for producing substituted pyridine-carboxylic acids |
| 08/06/2003 | CN1117077C 6-phenylpyridyl-2-amine derivatives useful asNOS inhibitors |
| 08/06/2003 | CN1117071C Pesticides |
| 08/05/2003 | US6603044 Phthalamide derivatives, or salt thereof agrohorticultural insecticide, and method for using the same |
| 08/05/2003 | US6603012 RAR selective retinoid agonists |
| 08/05/2003 | US6603011 3-pyridinyl compounds |
| 08/05/2003 | US6603010 Supernucleophilic 4-substituted-pyridine catalysts, and processes useful for preparing same |
| 08/05/2003 | US6603007 Bipyridyl derivatives |
| 08/05/2003 | US6603000 Making 1-amino-4-(substituted)-naphthalene compounds; useful in the production of heteroaryl ureas which are key component in drugs possessing a heteroaryl urea group |
| 08/05/2003 | US6602871 Thrombin or factor Xa inhibitors |
| 08/05/2003 | US6602441 Bleaching-active metal complexes |
| 08/05/2003 | CA2275827C Method for treating glaucoma |
| 08/01/2003 | CA2418410A1 Novel, water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases |
| 07/31/2003 | WO2003063555A1 Electroluminescent iridium compounds wiht fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 07/31/2003 | WO2003062228A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection |
| 07/31/2003 | WO2003062222A1 Pyrazolecarboxamides, intermediates thereof and pesticides containing the same as the active ingredient |
| 07/31/2003 | WO2003062192A1 Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors |
| 07/31/2003 | WO2003062190A1 Compounds for modulating cell proliferation |
| 07/31/2003 | WO2003041649A3 Cyanoalkylamino derivatives as protease inhibitors |
| 07/31/2003 | WO2003027061A3 Muscarinic agonists |
| 07/31/2003 | WO2003020677A3 C2-substituted indane-1-ones and their derivatives, method for their production and their use as medicaments |
| 07/31/2003 | WO2003006016A3 Use of nk-1 receptor antagonists with pyridinic structure, for the treatment of brain, spinal or nerve injury |
| 07/31/2003 | WO2002094767A3 Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors |
| 07/31/2003 | WO2002062762A3 Potassium channel openers |
| 07/31/2003 | WO2002060875A8 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 07/31/2003 | WO2002020500A3 Materials and methods to potentiate cancer treatment |
| 07/31/2003 | US20030144541 Process for preparing alpha-halogenated retones |
| 07/31/2003 | US20030144526 Calcium receptor-active compounds |
| 07/31/2003 | US20030144525 Conjugated aromatic compounds with a pyridine substituent |
| 07/31/2003 | US20030144524 With an aromatic derivative carrying at least one hydroxyl functional group, wherein the electron-withdrawing group present on the carbonyl compound is selected from fluoroalkyl derivatives, esters, including orthoesters, and nitriles and |
| 07/31/2003 | US20030144523 Epothilone derivatives, method for producing same and their pharmaceutical use |
| 07/31/2003 | US20030144514 Bis-aryliminepyridine MXn complexes comprising a non-symmetrical ligand of formula (I), wherein M is a metal selected from Fe or Co, n is 2 or 3, and X is halide, optionally substituted hydrocarbyl, alkoxide, amide, or |
| 07/31/2003 | US20030144513 A ruthenium complex represented by the following formula: RuL1L2X wherein L1 represents a 2,2';6',2''-terpyridine compound having at least one group selected from a carboxyl group, a salt of a carboxyl group, a sulfonic acid group, a |
| 07/31/2003 | US20030144487 Directed to luminescent lanthanide compounds with phosphine oxide, phosphine oxide- sulfide, pyridine N-oxide, and phosphine oxide-pyridine N-oxide ligands. It also relates to electronic devices in which the active layer includes a |
| 07/31/2003 | US20030144342 alpha- and beta-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 07/31/2003 | US20030144328 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/31/2003 | US20030144327 Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl |
| 07/31/2003 | US20030144323 Phenylalkynes |
| 07/31/2003 | US20030144311 Propanoic acid derivatives as intergrin receptor antagonists |
| 07/31/2003 | US20030144285 Cholinergic agents such as 4-Butyl-1-(4-phenyl-4-oxo-1-butyl) piperidine, administered as cognition activators and for prophylaxis of vision defects |
| 07/31/2003 | US20030144278 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 07/31/2003 | US20030144276 Heterocycle-containing carboxylic acid derivative and drug containing the same |
| 07/31/2003 | US20030144274 Preferential enzyme inhibitors such as 3-(4-Methoxyphenyl)-prop-1-ynyl)-N-(4-carboxybenzyl)benzamide, used for prophylaxis of degenerative diseases including cancer and arthritis |